Flagship Biosciences released news today of their acquisition of IHCtech, a company founded by Patsy Ruegg in 2002 at the University of Colorado Health Sciences Center Pathology Department, that serves research investigators all over the U.S. with IHC services. This is an interesting development for Flagship Biosciences and would seem to create some vertical dimension to their already formidable service line for quantitative IHC analysis. Here's an excerpt from the press release (provided to me courtesy of Mr. Steven Potts, CEO and Chairman of Flagship):
“We have partnered with Flagship Biosciences on a number of new techniques and approaches for quantitation in immunohistochemistry,” said Patsy Ruegg, owner and founder of IHCtech. “Their approaches to whole slide analysis and commitment to quantitative pathology makes a perfect partner with IHCtech’s expertise in high quality histology and immunohistochemistry. We enthusiastically look to further innovation by evaluating all aspects of the tissue chain -- tissue procurement, fixation and processing, with the ability to measure with whole slide analysis how each of these steps contribute to variability in the overall process.”
“While Flagship Biosciences has established strong partnerships with a number of highly respected IHC laboratories, both within the United States and internationally, this acquisition gives us the opportunity to internally evaluate tissue staining and implement new processes that better equip immunohistochemistry operations for use in quantitative pathology with whole slide imaging analysis,” said Dr. David Young, President of Flagship Biosciences. “Patsy Ruegg’s leadership in the area of high-quality research immunohistochemistry has been clear for many years. She has been a consistent expert in new IHC techniques like dual staining as well as a longtime leader in training of histology personnel.”
Usual disclaimer that I have no financial relationship etc with either company--I'm just an innocent bystander passing along information. But I encourage you to visit Flagship's website.